Tumors require blood supply to grow beyond a certain size, and they hijack angiogenic pathways to build their own vascular networks
Afrin S, Alashqar A, El Sabeh M, Miyashita-Ishiwata M, Reschke L, Brennan JT, Fader A, Borahay MA
178,179,180 In 2004, the FDA approved the first aptamer drug, pegaptanib (Macugen), to treat choroidal neovascularization caused by neovascular age-related macular degeneration (AMD)
Cardiovascular Health: The weight loss induced by this medicine can result in improved heart health, reducing the risk of cardiovascular diseases such as hypertension, heart disease, and stroke
Safety disclosures, possible side effects, and medical appropriateness are determined through clinician review